GlassScriptPhysician profile
Brenda Chiang
NPI 1366067829
$766.89
in general payments reported to CMS, 2019-2025
8 companies · $638 in 2025
The $638 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $29.31 · 2024: $99.95 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $667 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $666.94 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $128.85 | 2025 | Reblozyl |
| Beone Medicines USA, INC. | $124.93 | 2025 | Brukinsa |
| Astellas Pharma US INC | $118.86 | 2025 | Xospata |
| Abbvie INC. | $114.26 | 2025 | |
| Exelixis INC. | $99.95 | 2024 | |
| Genmab U.S., INC. | $98.04 | 2025 | Epkinly |
| Tempus Ai, INC | $52.69 | 2025 | Xt Cdx |
| Janssen Pharmaceuticals, INC | $29.31 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenda Chiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.